GE HealthCare reports fourth quarter and full year 2025 financial results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- Wall Street ends higher as US, Iran attacks ease; major tech-related shares jump
- Tech funds suffer record outflows as investors trim equity positions
- Comcast shares surge 23% on blockbuster plan to spin off NBCUniversal and Sky
- New leader board: Citi refreshes AI compute semiconductor picks
- Martin Marietta confirms $13.5B deal for Lhoist North America
- Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
- Needham Starts NeoVolta (NEOV) at Buy
- Personalis, Inc. (PSNL) and Tempus (TEM) Expand Collaboration
- EchoStar Prepares Dish DBS Bankruptcy Filing as Soon as Tuesday - WSJ
- Strategy stock jumps 7% as firm shifts to active capital management
GE HealthCare (GEHC) PT Raised to $91 at BTIG
February 4, 2026 12:33 PM ESTBTIG analyst Ryan Zimmerman raised the price target on GE HealthCare (NASDAQ: GEHC) to $91.00 (from $87.00) while maintaining a Buy rating.
The analyst comments "We maintain our Buy and raise our PT to $91 (from $87) following 4Q25 results. Order growth came in at ~2.0% with a Book-to-Bill ratio of 1.06x off a more challenging... More
GE HealthCare (GEHC) Tops Q4 EPS by 4c, Beats on Revenue; Offers Guidance
February 4, 2026 6:22 AM ESTGE HealthCare (NASDAQ: GEHC) reported Q4 EPS of $1.44, $0.04 better than the analyst estimate of $1.40. Revenue for the quarter came in at $5.7 million versus the consensus estimate of $5.6 million.
Today, the Company introduces 2026 full-year guidance metrics as follows:
Organic revenue growth* of 3.0% to 4.0% year-over-year... More
